The findings were published in The Lancet Diabetes & Endocrinology ... the study expanded current knowledge about this class of drugs in key areas, including benefits in people with CKD, and ...
Sodium-glucose cotransporter-2 (SGLT2) inhibitors are a newer type of medication used to help manage diabetes. While these drugs are effective for controlling blood sugar, a recent study by the ...
Tirzepatide Shows Powerful Diabetes-Prevention Effect in Three-Year Trial Nov. 26, 2024 — Tirzepatide, a new injectable weight-loss drug, reduced the risk of diabetes in patients with obesity ...